Wolverine Trading’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.81M Buy
9,568
+6,672
+230% +$1.18M ﹤0.01% 2270
2025
Q2
$515K Sell
2,896
-6,429
-69% -$1.12M ﹤0.01% 2918
2025
Q1
$1.56M Buy
9,325
+3,804
+69% +$625K ﹤0.01% 1835
2024
Q4
$834K Buy
+5,521
New +$859K ﹤0.01% 2852
2024
Q3
Sell
-5,798
Closed -$866K 4898
2024
Q2
$794K Buy
+5,798
New +$794K ﹤0.01% 2409
2022
Q3
Sell
-1,642
Closed -$216K 4731
2022
Q2
$226K Sell
1,642
-691
-30% -$94.2K ﹤0.01% 3405
2022
Q1
$324K Sell
2,333
-3,525
-60% -$491K ﹤0.01% 3786
2021
Q4
$1M Sell
5,858
-23,578
-80% -$3.59M ﹤0.01% 2611
2021
Q3
$4.35M Sell
29,436
-6,802
-19% -$995K ﹤0.01% 1411
2021
Q2
$4.82M Buy
36,238
+20,524
+131% +$2.69M 0.01% 1175
2021
Q1
$2.02M Buy
15,714
+11,791
+301% +$1.45M ﹤0.01% 1922
2020
Q4
$464K Buy
+3,923
New +$478K ﹤0.01% 3260
2020
Q3
Sell
-4,261
Closed -$470K 4624
2020
Q2
$470K Buy
+4,261
New +$452K ﹤0.01% 2800
2020
Q1
Sell
-13,880
Closed -$1.44M 4733
2019
Q4
$1.48M Buy
13,880
+9,050
+187% +$944K ﹤0.01% 2071
2019
Q3
$510K Buy
+4,830
New +$496K ﹤0.01% 2608
2018
Q1
Sell
-18,132
Closed -$1.86M 5210
2017
Q4
$1.79M Buy
+18,132
New +$1.72M 0.01% 1648
2017
Q2
Sell
-2,686
Closed -$264K 4381
2017
Q1
$264K Buy
+2,686
New +$256K ﹤0.01% 3180

Other funds holding DGX

Wolverine Trading's DGX Position: Q3 2025 in Review

Wolverine Trading increased its Quest Diagnostics (DGX) stake by 230% in Q3 2025, buying an estimated $1.18M and bringing the position to 9,568 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2270.

Wolverine Trading first reported a position in DGX in Q1 2017 and has held it in 17 quarters since. The position peaked at $4.82M in Q2 2021. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Wolverine Trading held 9,568 shares of Quest Diagnostics worth $1.81M as of Q3 2025.
  • Wolverine Trading bought 6,672 Quest Diagnostics shares in Q3 2025, an estimated $1.18M.
  • Quest Diagnostics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2270 holding.
  • Wolverine Trading first reported a position in Quest Diagnostics in Q1 2017 and has held it in 17 quarters since.
  • Wolverine Trading's Quest Diagnostics position peaked at $4.82M in Q2 2021.
  • 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.